Part 7 · Reading Comprehension
- To:
- Sofia Leventis <s.leventis@nereusbio.com>
- From:
- Andreas Sarris <a.sarris@olympusventures.com>
- Date:
- September 12
- Subject:
- RE: Collaboration proposalRE: Đề xuất hợp tác
Dear Ms. Leventis,
Thank you for considering Olympus Ventures as a partner to help grow Nereus Biotech. After carefully reviewing your proposal, however, we have determined that it does not fit our strategic priorities for the year ahead. At the moment we are not looking to enter the biotechnology field and are instead concentrating on projects in renewable energy, logistics software, and advanced materials. In addition, we are presently forming partnerships only with companies that have already reached a late stage of product development.
We do recognize the promise of your idea and would like to suggest that you reach out to Delphi Growth Partners. Based in Athens, Delphi Growth Partners focuses on helping early-stage firms in the life-sciences sector. The company can put you in touch with investors who have the funding your business needs to move forward.
Thank you again for your interest, and we wish you every success in the months ahead.
Andreas Sarris
Senior Vice President, Olympus Ventures
Why does Mr. Sarris reject Ms. Leventis's proposal?
What is suggested about Nereus Biotech?
According to the e-mail, what could be a benefit of working with Delphi Growth Partners?